Skip to content
★ Sign in to follow
PM

Peregrine Moncreiffe

Chairman
Arix Bioscience plc
Total declarations
2
Company
1
▲ Purchases (2 ops.)
€118k
▼ Sales (0 ops.)
—

Latest filing published 05 Oct 2022 for Arix Bioscience plc, €118k.

Filing timeline

BuySale
Peregrine Moncreiffe

Insider track record

Disclosed buys
2
Disclosed sells
0
Signal history

No signal scores available.

Closed purchases

Market purchases
2

Not enough history yet: 0 closed purchases, at least 2 are needed.

Purchases by company

Peregrine Moncreiffe: trading record in brief

Peregrine Moncreiffe is a declared insider of Arix Bioscience plc, with filings sourced from RNS (LSE). In total, 2 filings cover trades dated from 16 December 2021 to 4 October 2022.

The open-market record is one-sided, with 2 purchases worth €118k and not one sale. The totals exclude 1 filing filed without an amount. Buying on the open market means paying the going price with one's own funds, a different act from receiving shares as pay. Since January 2022: 1 purchase and no sales on the market.

Most recently, on 5 October 2022, the filings show an open-market purchase worth €118k in Arix Bioscience plc. Every figure here comes from the filings published by RNS (LSE) and describes the past, not future prices; it is not investment advice.

Companies and markets linked to Peregrine Moncreiffe

Open company profiles for insider transactions, fundamentals and analyst consensus when available.

Declarations2 total
  • ▲
    Non-Executive Director and Chair of the BoardExecutivesArix Bioscience plc
    102,940 GBP15FCA-NSM
    100,000 shares@ £1.0294100.0% of flowOutside a trading venueISIN GB00BD045071FCA-NSM:RYDLDHYVAQPLGQCSXARKHQEK
    Canonical exit: 2 Jan 2023 (T+90)
  • ▲
    Non-Executive Director and Chair of the BoardExecutivesArix Bioscience plc
    0FCA-NSM
    84,000 sharesLondon Stock ExchangeISIN GB00BD045071FCA-NSM:4214871-1
    Canonical exit: 16 Mar 2022 (T+90)

2 of 2 declarations